Polypeptide inhibitors of lactate dehydrogenase activity for use in cancer therapy
(2021)
Files
1842EP-Avisderéceptionélectronique.pdf
Open Access - Adobe PDF
- 208.44 KB
Details
- Authors
- Abstract
- (en) The present invention relates to polypeptides that modulate the activity of native tetrameric lactate dehydrogenase, as active agents for cancer therapy. More particularly, the invention relates to polypeptides that inhibit the tetramerization of the lactate dehydrogenase subunits.
- Affiliations
Citations
Sonveaux, P., Thabault, L., Liberelle, M., & Frédérick, R. (2021). Polypeptide inhibitors of lactate dehydrogenase activity for use in cancer therapy (Patent No. EP21154636). https://hdl.handle.net/2078.5/258436